Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ-Reference-Cited by-同舟云学术

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

Published:1990-11 Issue:11 Volume:21 Page:1164-1167
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Bartkova Jirina,Barnes Diana M.,Millis Rosemary R.,Gullick W.J.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference29 articles.

1. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading;Berger;Cancer Res,1988

3. Expression of c-erbB-2 oncoprotein: A prognostic marker in human breast cancer;Wright;Cancer Res,1989

4. Studies of HER-2 neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

5. cERB2 oncogene expression in breast cancer: Relationships and prognostic significance;Lovekin;J Pathol,1989

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biomarkers in gastric cancer;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

2. Core needle biopsy of benign, borderline and in-situ problematic lesions of the breast: Diagnosis, differential diagnosis and immunohistochemistry;Annals of Diagnostic Pathology;2019-12

3. Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers;Oncology Reports;2019-07-04

4. Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ;Scientific Reports;2019-04-30

5. Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma;Histopathology;2018-10-29